Pharmaceuticals company Ajanta Pharma announced Q3FY25 results Revenue from operations at Rs 1,146 crore against Rs 1,105 crore; up 4%. EBITDA at Rs 321 crore against Rs 314 crore; up 2%; EBITDA at 28%. Profit after tax at Rs 233 crore against Rs 210 crore; up 11%; PAT at 20%. Result PDF